Neuroprotection for Ischemic Stroke: Moving Past Shortcomings and Identifying Promising Directions

The translation of neuroprotective agents for ischemic stroke from bench-to-bedside has largely failed to produce improved treatments since the development of tissue plasminogen activator (tPA). One possible reason for lack of translation is the failure to acknowledge the greatest risk factor for st...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Ryan C., Lucke-Wold, Brandon, Lucke-Wold, Noelle, Elliott, Alisa S., Logsdon, Aric F., Rosen, Charles L., Huber, Jason D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565354/
https://www.ncbi.nlm.nih.gov/pubmed/23344061
http://dx.doi.org/10.3390/ijms14011890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565354/
https://www.ncbi.nlm.nih.gov/pubmed/23344061
http://dx.doi.org/10.3390/ijms14011890

Ejemplares similares